InsidersTradesSigma
Browse the detailed record of transactions filed by Lars Öhman, Président du Conseil. Director active across 2 companies, notably Lipigon Pharmaceuticals AB. In total, 1 reports have been recorded. The latest transaction was disclosed on 21 May 2025 — Purchase. Regulator: FIN-FSA. The full history is free.
1 of 1 declaration
Lars Öhman is the Chairman of Lipigon Pharmaceuticals AB. In this role, he oversees the activities of the board of directors and contributes to the strategic direction of the company. Lipigon Pharmaceuticals AB is a Swedish biopharmaceutical company. Lars Öhman plays a key role in the governance and development of the company.